ArticleNature microbiology2026
A deep mutational scanning-informed protein language model predicts SARS-CoV-2 evolution dynamics with spatiotemporal resolution.
Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From sites to structure to serology: a roadmap for structure-aware molecular evolution of antigenically evolving viruses.Journal of virology · 2026Review
- AI-Driven BCR Modeling for Precision Immunology.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Early identification of emerging dominant variants of pathogens such as SARS-CoV-2 is important for effective public health responses, yet existing approaches are not feasible for real-time surveillance. Here we introduce DeepCoV (DMS-Empowered Evolution Prediction of CoronaVirus), a deep-learning framework for the dynamic identification of emerging variants with high potential to become prevalent at spatiotemporal resolution. It integrates deep mutational scanning (DMS)-derived mutation phenotypes, evolutionary sequence data and epidemiological surveillance data reflecting human immune pressures. Benchmarked against logistic regression-based methods and representative deep-learning approaches in simulated retrospective surveillance scenarios, DeepCoV accurately forecasts the dominance of recently circulating lineages a month in advance, achieving a 90% reduction in false discovery rate while capturing temporal and geographic dynamics of variant spread and reconstructing their regional prevalence trajectories. It also identified mutational hotspots of Omicron-derived backbones in silico, revealing convergent evolution trends. This provides a scalable framework for timely identification of immune-evasive variants and critical mutations, providing actionable insights.
Indexed as
Identifiers
42204343What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.